Switching between allosteric and dimerization inhibition of HIV-1 protease

Chemistry and Biology

Volumn 12, Issue 4, 2005, Pages 439-444

  Bowman, Michael J ^a   Byrne, Simon ^a   Chmielewski, Jean ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 17844382141     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2005.02.004     Document Type: Article

References (34)

1. M.A. Navia, P.M.D. Fitzgerald, B.M. McKeever, C. Leu, J.C. Heimbach, W.K. Herber, I.S. Sigal, P.L. Darke, and J.P. Springer 3-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1 Nature 337 1989 615 620
2. M. Miller, J. Schneider, B.K. Sathyanarayana, M.V. Toth, G.R. Marshall, L. Clawson, L.M. Selk, S.B.H. Kent, and A. Wlodawer Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 Å resolution Science 246 1989 1148 1152
3. D.R. Davies The structure and function of the aspartic proteinases Annu. Rev. Biophys. Biophys. Chem. 19 1990 189 215
4. L.H. Pearl, and W.R. Taylor Sequence specificity of retroviral proteases Nature 328 1987 482
5. S. Oroslan, and R.B. Luftig Retroviral proteinases Curr. Top. Microbiol. Immunol. 157 1990 153 185
6. S. Crawford, and S.P. Goff A deletion mutation in the 5′ part of the Pol gene of Moloney Murine Leukemia-virus blocks proteolytic processing of the gag and pol polyproteins J. Virol. 53 1985 899 907
7. I. Katoh, Y. Yoshinaka, A. Rein, M. Shibuya, T. Odaka, and S. Oroszlan Murine leukemia-virus maturation-protease region required for conversion from immature to mature core form and for virus infectivity Virology 145 1985 280 292
8. N.E. Kohl, E. Emini, W. Schlief, L. Davis, J. Heimbach, R. Dixon, E. Scolnick, and I. Sigal Active human immunodeficiency virus protease is required for viral infectivity Proc. Natl. Acad. Sci. USA 85 1988 4686 4690
9. M.A. Sommerfelt, S.R.J. Petteway, G.B. Dreyer, and E. Hunter Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage J. Virol. 66 1992 4220 4227
10. L.M. Babe, J.R. Rose, and C.S. Craik Trans-dominant inhibitory human immunodeficiency virus type 1 proteinase monomers prevent protease activation and virion maturation Proc. Natl. Acad. Sci. USA 98 1995 10069 10073
11. J.R. Rose, L.M. Babe, and C.S. Craik Defining the level of human immunodeficiency virus type 1 protease activity required for HIV-1 particle maturation and infectivity J. Virol. 69 1995 2751 2758
12. S. Ren, and E.J. Lien Development of HIV protease inhibitors: a survey Prog. Drug Res. 57 2001 1 34
13. A. Wlodawer, and J. Vondrasek Inhibitors of HIV-1 protease: a major success of structure-assisted drug design Annu. Rev. Biophys. Biomol. Struct. 27 1998 249 284
14. S.G. Deeks, M. Smith, M. Holodniy, and J.O. Kahn HIV-1 protease inhibitors JAMA 227 1997 145 153
15. S.J. Little, S. Holte, J.-P. Routy, E.S. Daar, M. Markowitz, A.C. Collier, R.A. Koup, J.W. Mellors, E. Connick, and B. Conway Antiretroviral-drug resistance amoung patients recently infected with HIV N. Engl. J. Med. 347 2002 385 394
16. C. Flexner HIV-protease inhibitors N. Engl. J. Med. 338 1998 1281 1292
17. M.J. Todd, N. Semo, and E. Freire The structural stability of the HIV-1 protease J. Mol. Biol. 283 1998 475 488
18. A. Gustchina, and I.T. Weber Compatitve analysis of the sequences and structures of HIV-1 and HIV-2 proteases Proteins 10 1991 325 339
19. V. Miller International perspectives on antiretroviral resistance. Resistance to Protease Inhibitors J. Acquir. Immune Defic. Syndr. 26 2001 S34 S50
20. R. Zutshi, J. Franciskovich, M. Shultz, B. Schweitzer, P. Bishop, M. Wilson, and J. Chmielewski Targeting the dimerization interface of HIV-1 protease: inhibition with crosslinked interfacial peptides J. Am. Chem. Soc. 119 1997 4841 4845
21. M.D. Shultz, M.J. Bowman, Y.-W. Ham, X. Zhao, G. Tora, and J. Chmielewski Small-molecule inhibitors of HIV-1 protease dimerization derived from cross-linked interfacial peptides Angew. Chem. Int. Ed. Engl. 39 2000 2710 2713
22. Z.Y. Zhang, R.A. Poorman, L.L. Maggiora, R.L. Heinrikson, and F.J. Kezdy Dissociative inhibition of dimeric enzymes: kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide J. Biol. Chem. 266 1991 15591 15594
23. D.D. Loeb, C.A.D. Hutchinson, M.H. Edgell, W.G. Farmerie, and R. Swanstrom Mutational analysis of human immunodeficiency virus type-1 protease suggests functional homology with aspartic proteinases J. Virol. 63 1989 111 121
24. A. Wlodawer, and J.W. Erickson Structure-based inhibitors of HIV-1 protease Annu. Rev. Biochem. 62 1993 543 585
25. T. Yonetani, and H. Theorell Studies on liver alcohol dehydrogenase complexes III. Multiple inhibition kinetics in the presence of two competitive inhibitors Arch. Biochem. Biophys. 106 1964 243 251
26. A.D. Richards, R. Roberts, B.M. Dunn, M.C. Graves, and J. Kay Effective Blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases FEBS Lett. 247 1989 113 117
27. P.M.D. Fitzgerald, B.M. McKeever, J.F. VanMiddlesworth, J.P. Springer, J.C. Heimbach, C.-T. Leu, W.K. Herber, R.A.F. Dixon, and P.L. Darke Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-Å resolution J. Biol. Chem. 265 1990 14209 14219
28. M.J. Todd, and E. Freire The effect of inhibitor binding on the structural stability and cooperativity of the HIV-1 protease Prot. Struct. Funct. Genet. 36 1999 147 156
29. A.M. Felix Cleavage of protecting groups with boron tribromide J. Org. Chem. 39 1974 1427 1429
30. M.V. Toth, and G.R. Marshall A simple, continuous fluorometric assay for HIV protease Int. J. Pept. Protein Res. 36 1990 544 550
31. M.D. Shultz, Y.-W. Ham, S.-G. Lee, D. Davis, C. Brown, and J. Chmielewski Small molecule dimerization inhibitors of HIV protease: a focused library approach J. Am. Chem. Soc. 126 2004 9886 9887
32. D.M.T. Chan, K.L. Monaco, R.-P. Wang, and M.P. Winters New N- and O-arylations with phenylboronic acids and cupric acetate Tetrahedron Lett. 39 1998 2933 2936
33. D.A. Evans, J.L. Katz, and T.R. West Synthesis of diaryl ethers through the copper-promoted arylation of phenols with arylboronic acids. An expedient synthesis of thyroxine Tetrahedron Lett. 39 1998 2937 2940
34. H.J. Schramm, E. de Rosny, M. Reboud-Ravaux, J. Buttner, A. Dick, and W. Schramm Lipopeptides as dimerization inhibitors of HIV-1 protease Biol. Chem. 380 1999 593 596